Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis. 2017

Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
Institute of Pharmaceutical Sciences, ETH Zurich (Swiss Federal Institute of Technology), Zurich, Switzerland.

Activated leukocyte cell adhesion molecule (ALCAM) is expressed on various cell types, including leukocytes, endothelial cells, and certain tumor cells. Although ALCAM expression on tumor cells has been linked to tumor invasion and metastatic spread, the contribution of ALCAM expressed in cells forming the tumor stroma to cancer progression has not been investigated. In this study, ALCAM-deficient (ALCAM-/-) mice were used to evaluate the role of ALCAM in lung tumor growth and metastasis. ALCAM-/- mice displayed an altered blood vascular network in the lung and the diaphragm, indicative of an angiogenetic defect. The absence of ALCAM expression in cells forming the stromal tumor microenvironment profoundly affected lung tumor growth in three different i.v. metastasis models. In the case of Lewis lung carcinoma (LLC), an additional defect in tumor cell homing to the lungs and a resulting reduction in the number of lung tumor nodules were observed. Similarly, when LLC cells were implanted subcutaneously for the study of spontaneous tumor cell metastasis, the rate of LLC metastasis to the lungs was profoundly reduced in ALCAM-/- mice. Taken together, our work demonstrates for the first time the in vivo contribution of ALCAM to angiogenesis and reveals a novel role of stromally expressed ALCAM in supporting tumor growth and metastatic spread.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
May 2010, Oral oncology,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
February 2008, Nature immunology,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
May 2004, The Journal of investigative dermatology,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
May 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
February 2011, PloS one,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
May 2004, Chest,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
April 2019, Oncogene,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
January 2012, Molecular biology reports,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
May 2012, Journal of neurochemistry,
Ann-Helen Willrodt, and Michal Beffinger, and Martina Vranova, and Darya Protsyuk, and Katja Schuler, and Maria Jadhav, and Mathias Heikenwalder, and Maries van den Broek, and Lubor Borsig, and Cornelia Halin
December 2015, Oncotarget,
Copied contents to your clipboard!